MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-10-0003822
Sionc Pharmaceuticals Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹147.51 Cr
▲ 13% YoY
Net profit · FY 2024
₹14.4 Cr
Net margin 9.8%
EBITDA · FY 2024
₹35.88 Cr
EBITDA margin 24.3%
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹12.15 Cr
Issued & subscribed
Open charges
₹133.78 Cr
Satisfied ₹59.73 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
324
Provident fund records
About Sionc Pharmaceuticals Private Limited
Data last updated:
Sionc Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2008PTC057417. Its GSTIN is 37AALCS7973C1ZW (Andhra Pradesh).
The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.15 Cr. It is led by directors including Baburao Dandamudi (Managing Director) and Manikreddy Pullagurla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 43 – 11 – 56 Subbalakshmi Nagar, Visakhapatnam, Andhra Pradesh, India – 530016.
As per the financials filed for FY 2024, the company reported a revenue of ₹147.51 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹14.4 Cr (net margin 9.8%) and EBITDA of ₹35.88 Cr (EBITDA margin 24.3%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 14% over five years.
The company has about 324 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sionc Pharmaceuticals. As per MCA filings, the company has open charges of ₹133.78 Cr and satisfied charges of ₹59.73 Cr on record. Court records list 6 cases involving the company, including 6 filed by the company; 2 cases are pending. The company has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹17.83 Cr; the latest was in September 2021. Its 7 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Therapiva Private Limited with revenue of ₹148.94 Cr.
Sionc Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0003822). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sioncpharmaceuticals.com.
Company details
CIN U24232AP2008PTC057417
Registration Number 057417
Incorporation Date 01 February 2008
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0003822
Key People
Baburao Dandamudi Managing Director Manikreddy Pullagurla Director Srikanth Dandamudi Director Recognitions & Rankings of Sionc Pharmaceuticals
Contact details
Sionc Pharmaceuticals Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is sioncpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address43 – 11 – 56 Subbalakshmi Nagar, Visakhapatnam, Andhra Pradesh, India – 530016
- IndustryPharma, API Manufacturers
To see the full contact details of Sionc Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sionc Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sionc Pharmaceuticals operates one associated brand: Sionc Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical drugs and provides infrastructure for production in India. | sioncpharmaceuticals.com |
Business activity
The main business activity of Sionc Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sionc Pharmaceuticals Private Limited, buy the company report.
Financials of Sionc Pharmaceuticals Private Limited
FY 2024 filings availableSionc Pharmaceuticals Private Limited reported revenue of ₹147.51 Cr (up 13% YoY) for FY 2024.
Revenue · FY 2024
₹147.51 Cr ▲ 13%
Net profit · FY 2024
₹14.4 Cr margin 9.8%
EBITDA · FY 2024
₹35.88 Cr margin 24.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 18%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 16%
5 years · compounded
▲ 12%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 13% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.88 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.3% | ||||
| Net Profit Margin | 9.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sionc Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sionc Pharmaceuticals Private Limited
Sionc Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manikreddy Pullagurla Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Biolyx Lifesciences Private Limited and 5 more | Director | 21 May 2009 | 17 Years 5 Months | Current |
| Srikanth Dandamudi Also directs: Sionc Laboratories Private Limited | Director | 21 May 2009 | 17 Years 5 Months | Current |
| Subba Rao Jetti | Director | 01 Dec 2011 | 14 Years 10 Months | Current |
| Baburao Dandamudi Also directs: Susi Sea Foods Private Limited, Sionc Laboratories Private Limited | Managing Director | 01 Feb 2008 | 18 Years 8 Months | Current |
| Jagadeesh Babu Rangisetty Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Envozyme Feeds Private Limited and 5 more | Director | 01 Feb 2008 | 18 Years 8 Months | Current |
Peer comparison
Sionc Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Therapiva Private Limited | ₹148.94 Cr (FY 2021) | -23.0% | Secunderabad, Telangana, India | |||
| Unimark Remedies Limited | ₹148.77 Cr (FY 2018) | -19.0% | Mumbai, Maharashtra, India | |||
| Bafna Pharmaceuticals Limited | ₹148.6 Cr (FY 2025) | -5.0% | Chennai, Tamil Nadu, India | |||
| Atlas Life Sciences Private Limited | ₹148.18 Cr (FY 2022) | 35.0% | Ahmedabad, Gujarat, India | |||
| Sionc Pharmaceuticals Private Limitedthis company | ₹147.51 Cr (FY 2024) | ₹14.4 Cr | 9.8% | 13.0% | 324 | Visakhapatnam, Andhra Pradesh, India |
| Jay Finechem Private Limited | ₹145.44 Cr (FY 2025) | 187.0% | Mumbai, Maharashtra, India | |||
| Pulse Pharmaceuticals Private Limited | ₹145.08 Cr (FY 2024) | -1.0% | Hyderabad, Telangana, India | |||
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sionc Pharmaceuticals Private Limited, buy the company report.
Auditor
Sionc Pharmaceuticals Private Limited is audited by RAO&MANOJ ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAO&MANOJ ASSOCIATES | FY 2023 | 006396S |
Shareholding
The shareholding of Sionc Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sionc Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹133.78 Cr
Satisfied charges
₹59.73 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2025 | 101072229 | Hdfc Bank Limited | ₹27 Lakh | Open | |
| 20 Sep 2024 | 100985566 | Others | ₹30 Cr | Open | |
| 14 Mar 2023 | 100688679 | Hdfc Bank Limited | ₹29.72 Lakh | Open | |
| 25 Nov 2022 | 100695106 | Hdfc Bank Limited | ₹33.5 Lakh | Open | |
| 25 Nov 2021 | 100513982 | Hdfc Bank Limited | ₹102.88 Cr | Open |
To see the full charge records of Sionc Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Sionc Pharmaceuticals Private Limited has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹17.83 Cr; the latest was in September 2021.
Total deals
11
Secondary share transfers
7
Funding rounds
4
Disclosed funding
₹17.83 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Susi Sea Foods Private Limited |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Susi Sea Foods Private Limited , an individual |
| Apr 2013 | Funding round | ₹2.21 Cr | Investors: Biophore India Pharmaceuticals Private Limited , 3 individuals |
| Mar 2011 | Funding round | ₹9.17 Cr | Investors: Biophore India Pharmaceuticals Private Limited , 3 individuals |
To see the full deal history of Sionc Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sionc Pharmaceuticals Private Limited has 6 court cases on record: 6 filed by Sionc Pharmaceuticals. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
6
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 2 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Andhra Pradesh Industrial Infrastructure Corporation Ltd., and 2 others | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Andhra Pradesh Industrial Infrastructure Corporation Ltd. and 3 others | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Ap and 1 other | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against The State of Andhra Pradesh. and 1 other | Disposed |
To see the full case history of Sionc Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sionc Pharmaceuticals Private Limited was last rated by Brickwork on 21 Sep 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 21 Sep 2021 |
To see the full credit ratings and regulatory alerts of Sionc Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sionc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sionc Pharmaceuticals Private Limited has a workforce of 324 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
324
Active EPFO establishments
1
Employee growth
11.34%
GST
Sionc Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AALCS7973C1ZW | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sionc Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sionc Pharmaceuticals Private Limited has 8 board changes on record since 2008: 5 appointments and 3 cessations. The latest: Subba Rao Jetti ceased to be Additional Director on 29 Sep 2012.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 101072229 was registered on 29 Mar 2025.
AGM
Sionc Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100985566 was registered on 20 Sep 2024.
Filing
Sionc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with Hdfc Bank Limited of Rs. 102.88 Cr registered on 25 Nov 2021 with Charge ID 100513982 was modified on 25 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100688679 was registered on 14 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.34 Cr with Charge ID 100695106 was registered on 25 Nov 2022.
Charges
A charge registered on 11 Dec 2020 via Charge ID 100407407 with Others was fully satisfied on 07 Mar 2022.
Charges
A charge registered on 22 Jul 2016 via Charge ID 100046849 with Others was fully satisfied on 07 Mar 2022.
Charges
A charge registered on 14 Nov 2009 via Charge ID 10188941 with Others was fully satisfied on 07 Mar 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 102.88 Cr with Charge ID 100513982 was registered on 25 Nov 2021.
Charges
A charge with Others amounted to Rs. 7.38 Cr with Charge ID 100407407 was registered on 11 Dec 2020.
12 earlier events are in the company report.
Frequently asked questions
Sionc Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 February 2008 (18+ years old) and is registered under CIN U24232AP2008PTC057417.
Sionc Pharmaceuticals has 5 current directors:
- Baburao Dandamudi - Managing Director
- Manikreddy Pullagurla - Director
- Srikanth Dandamudi - Director
- Subba Rao Jetti - Director
- Jagadeesh Babu Rangisetty - Director
The latest financial statements of Sionc Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sionc Pharmaceuticals is 37AALCS7973C1ZW, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Sionc Pharmaceuticals is U24232AP2008PTC057417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sionc Pharmaceuticals has 6 court cases on record: 6 filed by the company. 2 are pending.
Sionc Pharmaceuticals was incorporated on 01 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Vijayawada.
Sionc Pharmaceuticals has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹17.83 Cr; the latest was in September 2021.
The peers of Sionc Pharmaceuticals by revenue are Therapiva Private Limited, Unimark Remedies Limited, Bafna Pharmaceuticals Limited, Atlas Life Sciences Private Limited, Jay Finechem Private Limited and 2 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Subba Rao Jetti ceased to be Additional Director on 29 Sep 2012. Subba Rao Jetti was appointed as Director on 01 Dec 2011. Manikreddy Pullagurla ceased to be Additional Director on 30 Sep 2010. Sionc Pharmaceuticals has 8 board changes on record in total.
Yes, Sionc Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0003822).